Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update

NEXT STORY
Curetis to Receive Additional EUR 6.5 Million Financing from EIB and Yorkville
PREV STORY
SIGA Announces Exercise of Option for the Purchase of Raw Materials for Oral TPOXX® Manufacturing Totaling $11 Million
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

XBiotech Announces First Patient in Clinical Study to Evaluate Bermekimab in Systemic Sclerosis

author_avatar
NASDAQ Market News

The industrial & institutional disinfectants & sanitizers market by revenue is expected to grow at a CAGR of 10.21% during the period 2020–2026

author_avatar
NASDAQ Market News

BioNTech Announces Pricing of Upsized Underwritten Offering and Terms of Rights Offering

author_avatar
NASDAQ Market News